期刊
LIPIDS
卷 43, 期 8, 页码 703-711出版社
WILEY
DOI: 10.1007/s11745-008-3183-4
关键词
tracer; kinetics; thin layer chromatography; uptake; clearance
资金
- NIDDK NIH HHS [DK-54902, R01 DK054902, U24-DK-59637, U24 DK059637, R01 DK050277, R56 DK054902] Funding Source: Medline
Insulin resistance is characterized by increased metabolic uptake of fatty acids. Accordingly, techniques to examine in vivo shifts in fatty acid metabolism are of value in both clinical and experimental settings. Partially metabolizable long chain fatty acid (LCFA) tracers have been recently developed and employed for this purpose: [9,10-H-3]-(R)-2-bromopalmitate ([H-3]-BROMO) and [I-125]-15-(rho-iodophenyl)-3-R,S-methylpentadecanoic acid ([I-125]-BMIPP). These analogues are taken up like native fatty acids, but once inside the cell do not directly enter beta-oxidation. Rather, they become trapped in the slower processes of omega and alpha-oxidation. Study aims were to (1) simultaneously assess and compare [H-3]-BROMO and [I-125]-BMIPP and (2) determine if tracer breakdown is affected by elevated metabolic demands. Catheters were implanted in a carotid artery and jugular vein of Sprague-Dawley rats. Following 5 days recovery, fasted animals (5 h) underwent a rest (n = 8) or exercise (n = 8) (0.6 mi/h) protocol. An instantaneous bolus containing both [H-3]-BROMO and [I-125]-BMIPP was administered to determine LCFA uptake. No significant difference between [I-125]-BMIPP and [H-3]-BROMO uptake was found in cardiac or skeletal muscle during rest or exercise. In liver, rates of uptake were more than doubled with [H-3]-BROMO compared to [I-125]-BMIPP. Analysis of tracer conversion by TLC demonstrated no difference at rest. Exercise resulted in greater metabolism and excretion of tracers with similar to 37% and similar to 53% of [I-125]-BMIPP and [H-3]-BROMO present in conversion products at 40 min. In conclusion, [H-3]-BROMO and [I-125]-BMIPP are indistinguishable for the determination of tissue kinetics at rest in skeletal and cardiac muscle. Exercise preferentially exacerbates the breakdown of [H-3]-BROMO, making [I-125]-BMIPP the analogue of choice for prolonged (> 30 min) experimental protocols with elevated metabolic demands.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据